Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.11 -0.04 (-3.48%)
At close: Nov 13, 2026 · 4:00 PM EST

Veraxa Biotech AG - Post de-SPAC (VRXA) Current Leases (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) recorded Current Leases of $321,669 in the quarter ended Dec 31, 2025, up 80.2% from $178,537 a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Current Leases (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC reported Current Leases of $310,090, up 74.4% from the prior year.

  • Across earlier years, Current Leases came in at $177,784 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Veraxa Biotech AG - Post de-SPAC 16.07 Mn 12.50 Mn - 324,737.90
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 324,737.90
Dec 31, 2024 173,157.73
API Access

Veraxa Biotech AG - Post de-SPAC Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=VRXA&period=max&api_key=YOUR_API_KEY